News
![3 large caps near 52-week lows with large dividends: https://www.marketbeat.com/logos/articles/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDRZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3bd185cbcb79ac7eb575a93baf92e9e5017d38b5/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240126063229_3-large-caps-near-52-week-lows-with-large-dividend.jpg?locale=us)
3 large caps near 52-week lows with large dividends
How fitting that Thursday night’s full moon was also referred to as the ‘wolf moon.’
U.S. stock indices howled to fresh all-time highs this week as the first full moon of 2024 lit up the evening
![Discover leads financial stocks higher, but is trouble lurking?: https://www.marketbeat.com/logos/articles/med_20240125194537_discover-leads-financial-stocks-higher-but-is-trou.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBellZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b1ef56b9302c85e619680c463b646b9e785d4aa9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125194537_discover-leads-financial-stocks-higher-but-is-trou.jpg?locale=us)
Discover leads financial stocks higher, but is trouble lurking?
Bank stocks and other financials tracked in the Financial Select Sector SPDR Fund (NYSEARCA: XLF) are rallying to two-year highs, with Discover Financial Services (NYSE: DFS) among the leaders.
![Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73381/AC-260124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd01ZYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--b6a82654ad117bf9c39c27c505a5d8111b718295/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-260124.001.png?locale=us)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Institutionelle Investoren vor Einstieg. Neuer 192% Biotech Aktientip nach 15.973%
26.01.24 08:02
London (www.aktiencheck.de, Anzeige)
![Abbott Laboratories on track for new highs in 2024: https://www.marketbeat.com/logos/articles/med_20240125084342_chart-abt-1252024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMThYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1bc09bf8706052cc87093d6ad0f0db9ca5de4fe0/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125084342_chart-abt-1252024ver001.png?locale=us)
Abbott Laboratories on track for new highs in 2024
Abbott Laboratories (NYSE: ABT) share price fell following its Q4 2023 results, but investors should be cheering the news. The decline is a response to a report that was largely as expected, with
![Super Micro Computer hits record high ahead of its earnings: https://www.marketbeat.com/logos/articles/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUVYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--2d8a976d304914e6ad96f59f9f83d298cce5c665/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125082645_super-micro-computer-hits-record-high-ahead-of-its.jpg?locale=us)
Super Micro Computer hits record high ahead of its earnings
Super Micro Computer (NASDAQ: SMCI), a major standout in the tech stock arena, experienced a remarkable 36% surge last Friday, reaching a new all-time high after the stock broke out of a
![The EV bubble burst: Tesla looks to the future but wait to buy in: https://www.marketbeat.com/logos/articles/med_20240125072305_chart-tsla-1252024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMDhYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--840c0b565f02f439ca9905328dc4d7e4f6e398b7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125072305_chart-tsla-1252024ver001.png?locale=us)
The EV bubble burst: Tesla looks to the future but wait to buy in
If the last year of price cuts and sluggish sales weren’t enough to tip off the market to the fact the EV bubble has burst, Tesla’s (NASDAQ: TSLA) Q4 results and outlook for 2024 should do it. The
![When does 3M’s stumble become a buy?: https://www.marketbeat.com/logos/articles/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMUFYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dcfbd55352d682ee70c305a6527f5c9fc37160a1/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125070519_when-does-3ms-stumble-become-a-buy.jpg?locale=us)
When does 3M’s stumble become a buy?
Having put in what looked like a bottom last October, investors in 3M Co (NYSE: MMM) would have been looking ahead to 2024 with bullish optimism. Sure, the stock had sunk 60% since the summer of
![This one wireless service stock could blow past earnings: https://www.marketbeat.com/logos/articles/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeTBYYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--adb6e5732bfe96f42df4893e6fdc7d15de813a22/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124122029_this-one-wireless-service-stock-could-blow-past-ea.jpg?locale=us)
This one wireless service stock could blow past earnings
Now that the Federal Reserve (the Fed) has pivoted its strategy to the opposite end of where it had been throughout 2023, meaning they are now proposing to cut interest rates after an aggressive
![Verizon and AT&T: One is a high-yield value, the other a trap: https://www.marketbeat.com/logos/articles/med_20240124114037_chart-vz-att-1242023ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzBXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3b7e0ef167936d206ac98ef741fbb5a5b80b8750/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124114037_chart-vz-att-1242023ver001.png?locale=us)
Verizon and AT&T: One is a high-yield value, the other a trap
Verizon Communications Inc. (NYSE: VZ) and AT&T Inc. (NYSE: T) have presented value and yield to investors for years.
However, they failed to sustain interest in their stocks, creating a drag on
![These 5 growth stocks are now in buy ranges: https://www.marketbeat.com/logos/articles/med_20240125065914_these-5-growth-stocks-are-now-in-buy-ranges.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3NXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d1449d87eff5ec63be63f510265fc5a83e7777d3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240125065914_these-5-growth-stocks-are-now-in-buy-ranges.jpg?locale=us)
These 5 growth stocks are now in buy ranges
Chart patterns and consolidations are worth watching, as they provide actionable guidance for making a purchase.
With the recent uptrend in large-cap stocks, as reflected by the performance of
![Eilt: Durchbruch in Krebstherapie - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73376/AC-250124.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL2NXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--51e8f43bc76027b0a55cfc091add53df0fbcc148/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/AC-250124.001.png?locale=us)
Eilt: Durchbruch in Krebstherapie - Institutionelle Investoren vor Einstieg. Massives Kaufsignal. Neuer 224% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in Krebstherapie - Institutionelle Investoren vor Einstieg. Neuer 224% Biotech Hot Stock nach 134.452%
25.01.24 08:03
London (www.aktiencheck.de , Anzeige)
![Food fight! Which grocery store stocks will win in 2024?: https://www.marketbeat.com/logos/articles/med_20240124122319_food-fight-which-grocery-store-stocks-will-win-in.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzhXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--7df2b5afc964d3530a54c72d23ac9340c2bf41dc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124122319_food-fight-which-grocery-store-stocks-will-win-in.jpg?locale=us)
Food fight! Which grocery store stocks will win in 2024?
Food distributors and retailers are living up to their reputation as the best consumer staples industry to own.
Up 2.1% year-to-date, the group has a sizable early lead over its roughly flat sec
![Intuitive Surgical’s post-earnings dip is a healthy time to buy: https://www.marketbeat.com/logos/articles/med_20240124145004_chart-isrg-1242024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBL3dXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--74b2b11532bc44928a7d138b53c2a9d47f4b17d2/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124145004_chart-isrg-1242024ver001.png?locale=us)
Intuitive Surgical’s post-earnings dip is a healthy time to buy
Intuitive Surgical (NASDAQ: ISRG) share prices surged following the Q4 release but failed to hold the gain, creating an ugly candle capping a strong rally. The market may move lower from here, but
![5 top healthcare stocks for earnings growth in 2024: https://www.marketbeat.com/logos/articles/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBLzRXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--603b6f3363f5b803bb05f2ff2c902c3d9e326b9c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124120518_5-top-healthcare-stocks-for-earnings-growth-in-202.jpg?locale=us)
5 top healthcare stocks for earnings growth in 2024
While the healthcare sector delivered lackluster profit growth in 2023, it should change this year.
Sector components forecast to show the biggest earnings year-over-year earnings improvement
![Why Apple’s about to smash through $200 and continue: https://www.marketbeat.com/logos/articles/med_20240124111807_why-apples-about-to-smash-through-200-and-continue.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFVXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--1727773504930f1490f188dd10e1f0c641431dcc/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124111807_why-apples-about-to-smash-through-200-and-continue.jpg?locale=us)
Why Apple’s about to smash through $200 and continue
Microsoft Corporation (NASDAQ: MSFT) recently overtook Apple Inc. (NASDAQ: AAPL) as the world's most valuable company while also setting its all-time high; expectations are high for Apple to make
![Will leverage and pricing power drive Netflix to a record high?: https://www.marketbeat.com/logos/articles/med_20240124071952_chart-nflx-1242024ver001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd0FXYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--bd153e85e3bae974925aec1768a1450ad12c1c1f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124071952_chart-nflx-1242024ver001.png?locale=us)
Will leverage and pricing power drive Netflix to a record high?
The Netflix Inc. (NASDAQ: NFLX) narrative is not without risk. The company struggled with growth following the COVID-19 bubble, but those days are behind. The story today is leverage, driven by
![3 just-upgraded energy stocks to put on your radar: https://www.marketbeat.com/logos/articles/med_20240124085415_3-just-upgraded-energy-stocks-to-put-on-your-radar.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBK2dWYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--820aaebefe179d666921b4f292cdbdb85b20bf67/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240124085415_3-just-upgraded-energy-stocks-to-put-on-your-radar.jpg?locale=us)
3 just-upgraded energy stocks to put on your radar
Last night saw the S&P 500 index close at a fresh all-time high. It's a remarkable achievement that didn't look as likely as recently as October. But since the prospect of a rate cut became quite
![Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal. Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73356/Aktiencheck240124_01.001.png](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBdzRWYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--dfc408a5357fd5f86d3ba9f42b583e708352ada7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Aktiencheck240124_01.001.png?locale=us)
Eilt: Institutionelle Investoren begeistert von innovativer Krebstherapie. Massives Kaufsignal. Neuer 199% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren begeistert von innovativer Krebstherapie. Neuer 199% Biotech Aktientip nach 15.973% mit BioNTech
24.01.24
London (www.aktiencheck.de, Anzeige)
Link
![Insiders buy Alibaba stock after $278 billion stimulus. What now?: https://www.marketbeat.com/logos/articles/med_20240123115954_insiders-buy-alibaba-stock-after-278-billion-stimu.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBN0VVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--5e8a7059137db332f566055197d3cb92f2382eee/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240123115954_insiders-buy-alibaba-stock-after-278-billion-stimu.jpg?locale=us)
Insiders buy Alibaba stock after $278 billion stimulus. What now?
Every once in a cycle, the market experiences hysteria, whether on the upside or the downside. These are some of the best moments to pick a direction to expose your portfolio to potentially
![3 reasons to buy Meta stock ahead of earnings: https://www.marketbeat.com/logos/articles/med_20240123084749_3-reasons-to-buy-meta-ahead-of-earnings.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMm9VYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--e4f821ed23b3a1b65029555315dac294f392dfc8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240123084749_3-reasons-to-buy-meta-ahead-of-earnings.jpg?locale=us)
3 reasons to buy Meta stock ahead of earnings
Meta Inc (NASDAQ: META) reports Thursday of next week in what will be one of the more closely watched reports of the year so far. The tech giant ended 2023 on a high, and its rally has, for the
![Three defensive stocks to hedge your risks this year: https://www.marketbeat.com/logos/articles/med_20240122121644_three-defensive-stocks-to-hedge-your-risks-this-ye.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBMndVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--0a879958bbda928f81a92f76b8fe581f34da4a5f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240122121644_three-defensive-stocks-to-hedge-your-risks-this-ye.jpg?locale=us)
Three defensive stocks to hedge your risks this year
As the new market cycle starts, a few uncertainties come with how the Federal Reserve (the Fed) will potentially cut interest rates. Some traders still need to buy the promises, judging by how
![Why the market is overpaying for Netflix stock ahead of earnings: https://www.marketbeat.com/logos/articles/med_20240122130616_why-the-market-is-overpaying-for-netflix-stock-ahe.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1FVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3efef4f0b95d69fffc9a61190884193eaf5bf34c/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240122130616_why-the-market-is-overpaying-for-netflix-stock-ahe.jpg?locale=us)
Why the market is overpaying for Netflix stock ahead of earnings
Never fight the market, and remember that the trend is your friend. This is why Netflix (NASDAQ: NFLX) stock should be flashing across your watchlist today. The trend in this stock shows a
![Ceragon is the under-the-radar networking stock you should know: https://www.marketbeat.com/logos/articles/med_20240121161314_chart-crnt.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd2tVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--9b1a4e69f0fcd61d3ffa5b1c48634c26714a45e9/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240121161314_chart-crnt.jpg?locale=us)
Ceragon is the under-the-radar networking stock you should know
Ceragon Networks Ltd. (NASDAQ: CRNT) is a provider of high-performance wireless infrastructure solutions to cellular operators and wireless service providers. It offers wireless backhaul solutions
![Sarepta Therapeutics Inc.: Why it's a rising gene therapy star: https://www.marketbeat.com/logos/articles/med_20240121162239_chart-srpt.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd1lVYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d0756421fca662f03802009a529767aacc622332/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240121162239_chart-srpt.jpg?locale=us)
Sarepta Therapeutics Inc.: Why it's a rising gene therapy star
Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a leading commercial-stage biotech focused on developing precision gene therapy treatments for rare diseases. This medical sector company specializes in
![3 top rated Chinese stocks in prime value territory: https://www.marketbeat.com/logos/articles/med_20240122130243_3-top-rated-chinese-stocks-in-prime-value-territor.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBd29VYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--cbf93a147c881864daf7f409ae9cbfa5ac1f206f/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20240122130243_3-top-rated-chinese-stocks-in-prime-value-territor.jpg?locale=us)
3 top rated Chinese stocks in prime value territory
As China's economy continues to face headwinds entering the new year, recent data has unveiled a harsh stock market sell-off, impacting U.S.-listed Chinese stocks such as Alibaba (NYSE: BABA),